MK-507 versus Sezolamide
- 1 March 1991
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 98 (3) , 308-313
- https://doi.org/10.1016/s0161-6420(91)32295-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.British Journal of Ophthalmology, 1990
- MK-927, A Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1990
- The Ocular Hypotensive Effect of the Topical Carbonic Anhydrase Inhibitor L-671,152 in Glaucomatous MonkeysArchives of Ophthalmology (1950), 1990
- MK-927: A Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1990
- MK-927: A Topically Active Ocular Hypotensive Carbonic Anhydrase InhibitorJournal of Ocular Pharmacology and Therapeutics, 1990
- A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animalsCurrent Eye Research, 1990
- The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeysCurrent Eye Research, 1990
- Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucomaJournal of Medicinal Chemistry, 1989
- MK-927: A Topically Effective Carbonic Anhydrase Inhibitor in PatientsArchives of Ophthalmology (1950), 1989
- Local Tolerance and Activity of MK-927, a Novel Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1988